Avelumab in Relapsed and Refractory Peripheral T-cell Lymphoma
Clinical trial NCT03046953 · COMPLETED
Trial details
- NCT number
- NCT03046953
- Sponsor
- University of Birmingham
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-08
- Primary completion
- 2020-07-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.